204 related articles for article (PubMed ID: 24725020)
21. Current Trends in Precision Medicine and Next-Generation Sequencing in Head and Neck Cancer.
Solis RN; Silverman DA; Birkeland AC
Curr Treat Options Oncol; 2022 Feb; 23(2):254-267. PubMed ID: 35195839
[TBL] [Abstract][Full Text] [Related]
22. Past and future impact of next-generation sequencing in head and neck cancer.
Sethi N; MacLennan K; Wood HM; Rabbitts P
Head Neck; 2016 Apr; 38 Suppl 1():E2395-402. PubMed ID: 25900457
[TBL] [Abstract][Full Text] [Related]
23. [Recent advances in early diagnosis of head and neck cancer in precision medicine era].
Min MK; Zhu MH; Zheng HL
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2017 Nov; 31(22):1770-1774. PubMed ID: 29798197
[TBL] [Abstract][Full Text] [Related]
24. Effect of human papillomavirus-16 infection on CD8+ T-cell recognition of a wild-type sequence p53264-272 peptide in patients with squamous cell carcinoma of the head and neck.
Sirianni N; Ha PK; Oelke M; Califano J; Gooding W; Westra W; Whiteside TL; Koch WM; Schneck JP; DeLeo A; Ferris RL
Clin Cancer Res; 2004 Oct; 10(20):6929-37. PubMed ID: 15501971
[TBL] [Abstract][Full Text] [Related]
25. Mutant allele tumor heterogeneity (MATH) and head and neck squamous cell carcinoma.
Rocco JW
Head Neck Pathol; 2015 Mar; 9(1):1-5. PubMed ID: 25804377
[TBL] [Abstract][Full Text] [Related]
26. MicroRNAs as new biomarkers for human papilloma virus related head and neck cancers.
Wang Y; Wang J; Huang Y
Cancer Biomark; 2015; 15(3):213-8. PubMed ID: 25769448
[TBL] [Abstract][Full Text] [Related]
27. MATH, a novel measure of intratumor genetic heterogeneity, is high in poor-outcome classes of head and neck squamous cell carcinoma.
Mroz EA; Rocco JW
Oral Oncol; 2013 Mar; 49(3):211-5. PubMed ID: 23079694
[TBL] [Abstract][Full Text] [Related]
28. No evidence of oncogenic KRAS mutations in squamous cell carcinomas of the anogenital tract and head and neck region independent of human papillomavirus and p16(INK4a) status.
Prigge ES; Urban K; Stiegler S; Müller M; Kloor M; Mai S; Ottstadt M; Lohr F; Wenz F; Wagner S; Wittekindt C; Klussmann JP; Hampl M; von Knebel Doeberitz M; Reuschenbach M
Hum Pathol; 2014 Nov; 45(11):2347-54. PubMed ID: 25257576
[TBL] [Abstract][Full Text] [Related]
29. Human papillomavirus type 16 E6 and E7 genotypes in head-and-neck carcinomas.
Hoffmann M; Lohrey C; Hunziker A; Kahn T; Schwarz E
Oral Oncol; 2004 May; 40(5):520-4. PubMed ID: 15006625
[TBL] [Abstract][Full Text] [Related]
30. Human papillomavirus E7 serology and association with p16 immunohistochemistry in squamous cell carcinoma of the head and neck.
Khanal S; Joh J; Kwon AM; Zahin M; Perez CA; Dunlap NE; Silverman CL; Tennant PA; Potts KL; Kloecker GH; Bumpous JM; Ghim SJ; Jenson AB; Redman RA
Exp Mol Pathol; 2015 Oct; 99(2):335-40. PubMed ID: 26116154
[TBL] [Abstract][Full Text] [Related]
31. The mutational spectrum of squamous-cell carcinoma of the head and neck: targetable genetic events and clinical impact.
Mountzios G; Rampias T; Psyrri A
Ann Oncol; 2014 Oct; 25(10):1889-1900. PubMed ID: 24718888
[TBL] [Abstract][Full Text] [Related]
32. Genomic landscape of human papillomavirus-associated cancers.
Rusan M; Li YY; Hammerman PS
Clin Cancer Res; 2015 May; 21(9):2009-19. PubMed ID: 25779941
[TBL] [Abstract][Full Text] [Related]
33. Core classification of head and neck squamous cell carcinomas: correlations between morphology, DNA ploidy and HPV infection.
Kotb WF; Blind C; Friedrich KH; Schewe C; Zhang ZG; Zheng JM; Deutschman N; Pacyna-Gengelbach M; Dietel M; Petersen I
Pathol Res Pract; 2010 Nov; 206(11):768-71. PubMed ID: 20850227
[TBL] [Abstract][Full Text] [Related]
34. Human papilloma virus and p53 in head and neck cancer: clinical correlates and survival.
Haraf DJ; Nodzenski E; Brachman D; Mick R; Montag A; Graves D; Vokes EE; Weichselbaum RR
Clin Cancer Res; 1996 Apr; 2(4):755-62. PubMed ID: 9816227
[TBL] [Abstract][Full Text] [Related]
35. Impact of genetic targets on therapy in head and neck squamous cell carcinoma.
Chaikhoutdinov I; Goldenberg D
Adv Exp Med Biol; 2013; 779():165-77. PubMed ID: 23288639
[TBL] [Abstract][Full Text] [Related]
36. HPV Infection of the Head and Neck Region and Its Stem Cells.
Pullos AN; Castilho RM; Squarize CH
J Dent Res; 2015 Nov; 94(11):1532-43. PubMed ID: 26353884
[TBL] [Abstract][Full Text] [Related]
37. Next generation sequencing and its application in deciphering head and neck cancer.
Jessri M; Farah CS
Oral Oncol; 2014 Apr; 50(4):247-53. PubMed ID: 24440145
[TBL] [Abstract][Full Text] [Related]
38. The ARF-p16 gene locus in carcinogenesis and therapy of head and neck squamous cell carcinoma.
Yarbrough WG
Laryngoscope; 2002 Dec; 112(12):2114-28. PubMed ID: 12461329
[TBL] [Abstract][Full Text] [Related]
39. Genomic insights into head and neck cancer.
Beck TN; Golemis EA
Cancers Head Neck; 2016; 1():. PubMed ID: 29034103
[TBL] [Abstract][Full Text] [Related]
40. Prospective assessment of the clinical benefit of a tailored cancer gene set built on a next-generation sequencing platform in patients with recurrent or metastatic head and neck cancer.
Westbrook TC; Hagemann IS; Ley J; Chen K; Palka K; Liu J; Chen L; Oppelt P; Adkins D
Med Oncol; 2019 Dec; 37(2):12. PubMed ID: 31865465
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
